| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 09/25/2008 | US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | CA2681326A1 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/24/2008 | EP1972630A1 Purines as cysteine protease inhibitors |
| 09/24/2008 | CN100420443C Nucleotide analog composition and synthesis method |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/18/2008 | WO2008063232B1 Substituted pyrazolopyrimidines |
| 09/18/2008 | US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement |
| 09/17/2008 | EP1968971A1 Dioxolane derivates for the treatment of cancer |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | CN101268039A Novel carboxylic acid derivatives |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/16/2008 | CA2427221C Process and intermediates for preparing anti-cancer compounds |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 09/12/2008 | WO2008109417A1 Mgmt inhibitor combinations for the treatment of neoplastic disorders |
| 09/12/2008 | WO2008108508A1 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 09/12/2008 | WO2008107873A1 Mercaptopurine derivatives as anticancer agents |
| 09/12/2008 | WO2008107418A1 Fused pyrimidinone compounds as mglur ligands |
| 09/12/2008 | WO2008107368A1 Purines as cysteine protease inhibitors |
| 09/12/2008 | CA2680179A1 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 09/12/2008 | CA2679700A1 Mercaptopurine derivatives as anticancer agents |
| 09/12/2008 | CA2679103A1 O6-alkylguanine-dna alkyltransferase inactivators |
| 09/12/2008 | CA2678463A1 Fused pyrimidinone compounds as mglur ligands |
| 09/11/2008 | US20080221134 Parkinson's disease, catalepsy, dystonia, dyskinetic syndrome, restless legs syndrome, migraine, pain, dementia, neurodegenerative disorders, alcohol withdrawal and/or ischemic conditions such as e.g. stroke or cardiac ischemia. |
| 09/11/2008 | US20080221133 Compounds |
| 09/11/2008 | US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents |
| 09/11/2008 | US20080221020 Dendrimers as Molecular Translocators |
| 09/11/2008 | US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates |
| 09/10/2008 | EP1966210A2 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 09/10/2008 | CN101260125A Method for extracting tea polyphenols by secondary solvent leaching method |
| 09/09/2008 | US7423144 Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 09/09/2008 | US7423041 e.g. 3-[2-(4-Aminophenyl)ethyl]-8-benzyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 09/04/2008 | US20080214582 treatment of tumors; 1-[4-(6-aminopurin-9-yl)-;phenyl]-3-[2-(pyrrolidin-3-yloxy)-5-trifluoromethylphenyl]-;urea; psoriasis, arthritis, inflammation, endometriosis, scarring, benign prostatic hyperplasia, immunological diseases, autoimmune diseases and immunodeficiency diseases |
| 09/04/2008 | US20080214581 anti-inflammatory; (2R,3S,4R,5R)-2-(2-ethyl-2H-tetrazol-5-yl)-5-[2-{[2-(1H-imidazol-4-yl)ethyl]amino}-6-({trans-4-[(2-{[2-(1H-imidazol-4-yl)ethyl]amino}-1H-purin-6-yl)amino]cyclohexyl}amino)-9H-purin-9-yl]tetrahydro-3,4-furandiol; immunosuppressive agents use in treatment of auto-immune diseases |
| 09/04/2008 | US20080214580 6-substituted 2-(benzimidazolyl)purine or purinones and 6-substituted 2-(imidazolo[4,5-c]pyridinyl)purine or purinones; Jak3 tyrosine kinase inhibitors; autoimmune and mast cell-mediated diseases, transplant rejection; antiinflammatory agents |
| 09/04/2008 | US20080214541 Such as 2-(1-naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; differentiating cells into osteoblast lineage; osteoporosis |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/03/2008 | EP1963325A2 Xanthine derivatives, processes for preparing them and their uses |
| 09/03/2008 | EP1962863A2 Orally active purine-based inhibitors of heat shock protein 90 |
| 09/03/2008 | EP1962597A2 Purine derivatives and methods of use thereof |
| 09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2008 | CN100415748C A2B adenosine receptor antagonists |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/02/2008 | CA2243237C Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
| 08/28/2008 | WO2008101514A1 Nucleoside analogues for the treatment of viral infections and methods for preparing them |
| 08/28/2008 | US20080207891 Methods For Selective N-9 Glycosylation of Purines |
| 08/28/2008 | US20080207648 Organic Compounds |
| 08/27/2008 | EP1960372A1 Kinase inhibitors and their uses |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/21/2008 | WO2008098471A1 A crystalline form of entecavir, its preparation, pharmaceutical compositions thereof and uses |
| 08/21/2008 | US20080200483 Purine Derivatives for Use as Adenosin A-2A Receptor Agonists |
| 08/21/2008 | US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine |
| 08/20/2008 | CN101248074A Xanthine oxidase inhibitor |
| 08/20/2008 | CN101245068A Crystallization type entecavir, method of producing the same, pharmaceutical composition and uses thereof |
| 08/20/2008 | CN101245067A Process for producing entecavir and midbody |
| 08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2151801C 3'-modified oligonucleotide derivatives |
| 08/14/2008 | WO2007106561A3 Prevention and treatment of cancer and other diseases |
| 08/13/2008 | EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1386923B1 Novel adenine derivatives |
| 08/13/2008 | CN101240001A 2'-fluoro nucleotide |
| 08/13/2008 | CN101239980A Immunity receptor regulator couplet precursor, couplet and application thereof |
| 08/13/2008 | CN100410255C Inosine derivatives and production methods therefor |
| 08/12/2008 | US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives |
| 08/12/2008 | US7411065 Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids |
| 08/12/2008 | US7410990 Heterocyclic compounds |
| 08/07/2008 | WO2008094737A2 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 08/07/2008 | CA2676138A1 Compounds and compositions as kinase inhibitors |
| 08/06/2008 | EP1953162A1 Xanthin derivatives, their production and utilisation as medicine |
| 08/06/2008 | EP1951731A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/06/2008 | EP1725217B1 Processes for the preparation of solid dosage forms of amorphous valganciclovir hydrochloride |
| 08/06/2008 | EP1622908B1 Xanthine derivatives as a2b adenosine receptor antagonists |
| 08/06/2008 | CN101235034A Method for synthesizing entecavir |
| 08/06/2008 | CN100408580C Carbocyclic nucleoside semi-sulfate and its application for curing viral infection |
| 08/06/2008 | CN100408579C Xanthine derivative, production and use thereof as a medicament |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/05/2008 | US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 07/31/2008 | WO2008090237A1 Method for obtaining fibre-rich cocoa with low carbon hydrate and methylxanthine contents, suitable for animal feed, and resulting cocoa |
| 07/31/2008 | WO2008090181A1 Purine derivatives |
| 07/31/2008 | WO2008073687A3 Compounds and compositions as protein kinase inhibitors |
| 07/31/2008 | WO2008063232A3 Substituted pyrazolopyrimidines |
| 07/31/2008 | WO2007135380A3 Antiparasitic compounds and compositions |
| 07/31/2008 | WO2007134298A3 Therapeutic compounds and their use in cancer |
| 07/31/2008 | CA2674875A1 Purine derivatives |
| 07/30/2008 | CN101233135A Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV |
| 07/30/2008 | CN101233134A 制备泛昔洛韦和其它嘌呤衍生物 Preparation of famciclovir and other purine derivatives |
| 07/30/2008 | CN101233133A Hydrochlorides and hydrates of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their preparation and their use as medicaments |
| 07/30/2008 | CN101230065A Method for producing 9-[2(hydroxyl)propyl] adenine |
| 07/30/2008 | CN101230064A 9 methylene aryl substituted purine derivative |
| 07/30/2008 | CN101229168A Immunity excitant containing selenium |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/24/2008 | WO2008087839A1 Process for production of crystal of purine nucleoside compound |